| Herbalife Ltd. Announces Third Quarter 2009 Results and Provides Initial 2010 Guidance | LOS ANGELES--(BUSINESS WIRE)--Nov. 2, 2009--
Herbalife Ltd. (NYSE: HLF) today reported third quarter 2009 net sales
of $600.2 million, a decrease of 0.3 percent compared to the same period
of 2008, primarily reflecting the 780 basis point unfavorable impact
from currency fluctuations. Excluding the impact from currency
fluctuations, local currency year-over-year net sales were 7.5 percent
higher than third quarter 2008 results. For the quarter ended September
30, 2009, the company reported net income of $57.9 million, or $0.91 per
diluted share, compared to $58.1 million, or $0.89 per diluted share in
the third quarter of 2008, reflecting lower net sales and gross profit
margins attributable to unfavorable currency fluctuations, offset by a
lower effective tax rate and accretion from the company’s share
repurchase program. Excluding the impact from adjusting items in the
third quarter 2009 (1), adjusted net income was $54.1
million, or $0.85 in adjusted diluted earnings per share, reflecting a
decrease of 6.9 percent and 4.5 percent, respectively, compared to the
same period in 2008.
For the nine months ended September 30, 2009, the company produced cash
flow from operations of $227.3 million, paid dividends of $36.7 million,
invested $42.1 million in capital expenditures, repurchased $32.5
million in common stock and paid approximately $10.0 million for certain
acquired manufacturing assets. The company’s net debt balance (1)
at the end of the third quarter was $94.4 million, reflecting an
improvement of $106.3 million from December 2008.
“We were very pleased with our local currency sales growth of 7.5
percent that was driven by volume point growth of five percent this
quarter and was well ahead of our expectations. We believe that the
increase in volume continues to validate that our distributors are
gaining traction and momentum through the use of the daily consumption
sales model around the globe. The ongoing transformation of our business
is enabling distributors to offer Herbalife products to a broader
customer base which is allowing for deeper market penetration than in
the past”, said Chairman and Chief Executive Officer Michael O. Johnson.
“As we head into 2010, many of our key markets, led by engaged
distributors, are demonstrating the successful transition to a business
model more focused on daily consumption including the U.S., Taiwan,
Korea, Brazil and India.”
During the third quarter 2009 the company added 48,040 new Sales Leaders (2),
which is 8.7 percent lower than the same period in 2008. Additionally,
total Sales Leaders (2) decreased 5.4 percent to 437,125 in
the third quarter of 2009 compared to the same period in 2008. During
the third quarter 2009, the company's President's Team membership
increased 8.4 percent to 1,262 members versus the third quarter of 2008
and the company’s prestigious Chairman's Club and China Brand Ambassador
membership increased 8.3 percent to 39 members, versus the third quarter
of 2008.
1 See Schedule D – “Reconciliation of Non-GAAP Financial
Measures” for more detail 2 See Schedule titled “New
Sales Leaders by Region” and “Total Sales Leaders by Region” for more
detail
Business Highlights
During the third quarter the company hosted three Extravaganzas in
Europe: in Prague, Turin, and St. Petersburg along with an Extravaganza
in Mexico, which collectively were attended by over 32,400 distributors.
Additionally, Taiwan hosted an Herbalife University event, attended by
over 11,000, which focused on providing detailed training to qualifying
supervisors. Product launches during the quarter included Mango Herbal
Aloe Concentrate in the U.S., Formula 1 Meal Replacement Bar in 11
countries within EMEA, all three flavors of the Protein Bars in Russia
and Herbal Aloe Powder in China.
In early July 2009, China's Ministry of Commerce granted five additional
licenses for the company to conduct direct-selling business in the
provinces of Fujian, Shan’Xi, Sichuan, Hubei, and Shanghai. Licenses for
these new provinces became effective immediately, except Shanghai which
will be activated upon government review of our service outlets for
which the timing remains uncertain. Additionally, the company’s license
for Beijing, which was granted in July 2008 with the same exception as
noted above for Shanghai, is now active. The company now has
direct-selling licenses in 11 provinces representing an addressable
population of approximately 599 million. Additionally, the company
applied for five new provincial licenses in August 2009.
|
|
|
Third Quarter 2009 Regional Key Metrics
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume
|
|
Increase/
|
|
New
|
|
Increase/
|
|
Total
|
|
Increase/
|
|
|
|
Points
|
|
(Decrease)
|
|
Sales
|
|
(Decrease)
|
|
Sales
|
|
(Decrease)
|
|
Region
|
|
(Mil)
|
|
(Y/Y)
|
|
Leaders
|
|
(Y/Y)
|
|
Leaders
|
|
(Y/Y)
|
|
North America
|
|
207.6
|
|
2.4
|
%
|
|
10,569
|
|
(9.8
|
%)
|
|
87,348
|
|
(4.5
|
%)
|
|
Asia Pacific (excluding China)
|
|
148.2
|
|
36.1
|
%
|
|
13,262
|
|
25.9
|
%
|
|
89,750
|
|
11.2
|
%
|
|
EMEA
|
|
109.4
|
|
(5.8
|
%)
|
|
5,222
|
|
(13.7
|
%)
|
|
66,454
|
|
(11.5
|
%)
|
|
Mexico
|
|
126.4
|
|
(4.3
|
%)
|
|
6,132
|
|
(1.8
|
%)
|
|
64,438
|
|
(16.0
|
%)
|
|
South & Central America
|
|
102.2
|
|
0.7
|
%
|
|
6,376
|
|
(40.7
|
%)
|
|
84,936
|
|
(11.8
|
%)
|
|
China
|
|
32.3
|
|
6.8
|
%
|
|
6,479
|
|
(11.0
|
%)
|
|
44,199
|
|
6.3
|
%
|
The North America region reported volume points of 207.6 million in the
third quarter of 2009, reflecting an increase of 2.4 percent versus the
same period of 2008. Volume point growth in the U.S., the largest
country in the region, increased 2.8 percent compared to 2008,
reflecting an increase in the Latin market of 7.0 percent and a decrease
in the General market of 5.3 percent compared to the third quarter of
2008. New Sales Leaders in the region were 10,569 during the quarter
ended September 30, 2009, a decrease of 9.8 percent versus the same
period last year. Total Sales Leaders in the region decreased 4.5
percent to 87,348 as of September 30, 2009 versus September 30, 2008.
The Asia Pacific region reported volume points of 148.2 million in the
third quarter of 2009, reflecting an increase of 36.1 percent over the
same period of 2008. Top markets in this region were Taiwan, with volume
point growth of 37.2 percent; Korea, with volume point growth of 83.3
percent; Malaysia with volume point growth of 16.8 percent and India
with volume point growth of 111.4 percent, all compared to the same
period in 2008. New Sales Leaders in the region were 13,262 during the
quarter ended September 30, 2009, an increase of 25.9 percent versus the
same period last year. Total Sales Leaders increased 11.2 percent to
89,750 as of September 30, 2009 versus September 30, 2008.
The Europe, Middle East and Africa (EMEA) region reported volume points
of 109.4 million in the third quarter of 2009, reflecting a decrease of
5.8 percent versus the same period of 2008. The top market in this
region was Italy, with volume point growth of 6.7 percent compared to
the same period in 2008. New Sales Leaders in the region were 5,222
during the quarter ended September 30, 2009, a decrease of 13.7 percent
versus the same period last year. Total Sales Leaders in the region
decreased 11.5 percent to 66,454 as of September 30, 2009 versus
September 30, 2008.
The Mexico region reported volume points of 126.4 million in the third
quarter of 2009, reflecting a decrease of 4.3 percent versus the same
period of 2008. During the third quarter of 2008, the company began
collecting a Value Added Tax (VAT) from our Mexican distributors that
has had a negative impact on our financial results. Distributors in
Mexico previously paid zero percent VAT on their purchases for most of
our nutrition products. This effective price increase, which impacted
approximately 60 percent of our volume points in the Mexican market,
adversely affected sales in Nutrition Clubs, which are retail
price-sensitive, and as a result has caused volume to decline from
pre-VAT levels. We are continuing to challenge this assessment on
several fronts. New Sales Leaders in the Mexico region were 6,132 during
the quarter ended September 30, 2009, or 1.8 percent lower than the same
period last year. Total Sales Leaders in the region decreased 16.0
percent to 64,438 as of September 30, 2009 versus September 30, 2008.
The South and Central American region reported volume points of 102.2
million in the third quarter of 2009, reflecting an increase of 0.7
percent versus the same period of 2008. The top markets in this region
were Brazil, with volume point growth of 7.7 percent and Venezuela, with
a volume point increase of 36.8 percent, both compared to the same
period in 2008. New Sales Leaders in the region were 6,376 during the
quarter ended September 30, 2009, or 40.7 percent lower than the same
period last year. Total Sales Leaders in the region decreased 11.8
percent to 84,936 as of September 30, 2009 versus September 30, 2008.
The China region reported volume points of 32.3 million in the third
quarter of 2009, reflecting an increase of 6.8 percent over the same
period of 2008. The company is currently licensed for direct sales in 11
provinces. New Sales Employees in China were 6,479 during the quarter
ended September 30, 2009, a decrease of 11.0 percent versus the same
period last year. Total Sales Employees increased 6.3 percent to 44,199
as of September 30, 2009 versus September, 2008.
2009 Guidance
Based on current business trends and late September spot FX rates, the
company’s fourth quarter 2009 and fiscal 2009 guidance is provided
below. We expect to exchange most of our excess cash in Venezuela,
approximately 100 million Venezuelan Bolivars, for U.S. dollars during
the fourth quarter at a parallel exchange rate that is unfavorable to
the official exchange rate. In October 2009, we began, and will
continue, to repatriate exchanged U.S. dollars which would result in a
reduction of cash of approximately $30 million. The P&L impact of this
expected repatriation will be recognized in the fourth quarter of 2009
as well as in 2010, and is excluded from both periods’ guidance below.
Fourth Quarter - The company’s fourth quarter 2009 diluted earnings per
share guidance range is $0.88 to $0.91 (3) (4) (5) (6) on a
volume point growth of 8.5 percent to 9.5 percent and a net sales growth
of 15.5 percent to 16.5 percent compared to the same period in 2008,
respectively, and an effective tax rate range of 30.0 percent to 31.0
percent. Assuming constant currency levels from the fourth quarter of
2008, the company’s net sales growth range would be 11.0 percent to 12.0
percent and its diluted earnings per share range would be $0.79 to
$0.82. The company’s fourth quarter 2009 capital expenditures are
expected to be in the range of $18 to $23 million.
Fiscal 2009 - The company’s new full year diluted earnings per share
guidance is $3.19 to $3.22 (3) (4) (5) (6) on volume point
growth of 1.0 percent to 1.5 percent and a net sales decline of 2.5
percent to 3.0 percent compared to 2008, respectively, along with an
effective tax rate range of 30.5 to 31.0 percent. Assuming constant
currency levels from 2008, the company’s net sales growth range would be
3.0 percent to 4.0 percent and its diluted earnings per share range
would be $3.99 to $4.02. Full year 2009 capital expenditures are
expected in the range of $60 million to $65 million.
2010 Guidance
Based on current business trends and late September spot FX rates, the
company is initiating guidance for 2010 with a diluted earnings per
share guidance range of $3.50 to $3.65 (7) on a volume point
growth of 5.0 to 6.0 percent and a net sales growth of 11.0 percent to
13.0 percent compared to the same period in 2009, respectively, and an
effective tax rate range of 30.0 percent to 31.0 percent. The company’s
guidance for capital spending in 2010 is in the range of $65 to $75
million.
While 2010 guidance excludes the impact of repatriating approximately
100 million Venezuelan Bolivars of our existing excess cash in Venezuela
described above, 2010 guidance does include the ongoing repatriation of
excess cash generated in Venezuela during 2010 at rates which are
unfavorable to the official exchange rate. (8)
3 Excludes the potential impact of expenses relating to the
company’s December 2008 restructuring. 4 Excludes the
accretion/dilution impact should the company elect to repurchase shares
under its share repurchase program. 5 Excludes the
impact of repatriating dollars from Venezuela at an exchange rate which
is less favorable than the official exchange rate. 6
Excludes the impact of the expense resulting from an international
income tax audit settlement, expiration of statute of limitation on a
reserved issue, and the expected Q4 reversal of a prior adjustment to
income tax accrual. 7 Includes utilization of $50
million of the company’s share repurchase program. 8 Assumes
a Parallel rate of no more than 6.5 Bolivars to 1 Dollar.
Third Quarter Earnings Conference Call
Herbalife's senior management team will host an investor conference call
to discuss its third quarter 2009 financial results and provide an
update on current business trends on Tuesday, November 3 at 8 a.m. PST
(11 a.m. EST).
The dial-in number for this conference call for domestic callers is
(866) 219-5268 and (703) 639-1120 for international callers. Live audio
of the conference call will be simultaneously webcast in the Investor
Relations section of the company’s Web site at http://ir.Herbalife.com.
An audio replay will be available following the completion of the
conference call in MP3 format or by dialing (866) 837-8032 (domestic
callers) and (703) 925-2474 (international callers) and entering access
code 336024. The webcast of the teleconference will be archived and
available on Herbalife’s Web site.
2009 Analyst and Investor Day
Herbalife's senior management team will host its annual analyst and
investor day on December 17, 2009 in New York at the Four Seasons.
Chairman and CEO Michael O. Johnson and Chief Financial Officer Richard
Goudis will be joined by other members of Herbalife’s management team to
discuss the company’s initiatives and operations.
The presentation will be webcast in the investor relations section of
Herbalife’s Web site at https://ir.Herbalife.com
To register for the event, email investorrelations@herbalife.com
or call Amy Greene at 213.745.0504.
About Herbalife Ltd.
Herbalife
Ltd. (NYSE:HLF) is a global network marketing company that sells
weight-management, nutrition, and personal care products intended to
support a healthy lifestyle. Herbalife products are sold in 70 countries
through a network of approximately 1.9 million independent distributors.
The company supports the Herbalife
Family Foundation and its Casa Herbalife program to help bring good
nutrition to children. Herbalife’s Web site contains a significant
amount of information about Herbalife, including financial and other
information for investors at http://ir.Herbalife.com.
The company encourages investors to visit its Web site from time to
time, as information is updated and new information is posted.
Disclosure Regarding Forward-Looking Statements
This document contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as
amended. All statements other than statements of historical fact
are “forward-looking statements” for purposes of federal and
state securities laws, including any projections of earnings, revenue
or other financial items; any statements of the plans, strategies and
objectives of management for future operations; any statements
concerning proposed new services or developments; any statements
regarding future economic conditions or performance; any
statements of belief; and any statements of assumptions
underlying any of the foregoing. Forward-looking statements may include
the words “may,” “will,” “estimate,” “intend,” “continue,” “believe,”
“expect” or “anticipate” and any other similar words.
Although we believe that the expectations reflected in any of our forward-looking
statements are reasonable, actual results could differ materially
from those projected or assumed in any of our forward-looking statements.
Our future financial condition and results of operations, as well as
any forward-looking statements, are subject to change and to inherent
risks and uncertainties, such as those disclosed or incorporated
by reference in our filings with the Securities and Exchange
Commission. Important factors that could cause our actual
results, performance and achievements, or industry results to
differ materially from estimates or projections contained in our forward-looking
statements include, among others, the following:
• our relationship with, and our ability to influence the actions
of, our distributors;
• adverse publicity associated with our products or network
marketing organization;
• uncertainties relating to interpretation and enforcement of
recently enacted legislation in China governing direct selling;
• our inability to obtain the necessary licenses to expand our
direct selling business in China;
• adverse changes in the Chinese economy, Chinese legal system or
Chinese governmental policies;
• improper action by our employees or international distributors
in violation of applicable law;
• changing consumer preferences and demands;
• loss or departure of any member of our senior management team
which could negatively impact our distributor relations and operating
results;
• the competitive nature of our business;
• regulatory matters governing our products, including potential
governmental or regulatory actions concerning the safety or efficacy of
our products, and network marketing program including the direct selling
market in which we operate;
• third party legal challenges to our network marketing program;
• risks associated with operating internationally, including
foreign exchange and devaluation risks;
• our dependence on increased penetration of existing markets;
• contractual limitations on our ability to expand our business;
• our reliance on our information technology infrastructure and
outside manufacturers;
• the sufficiency of trademarks and other intellectual property
rights;
• product concentration;
• our reliance on our management team;
• uncertainties relating to the application of transfer pricing,
duties, value added taxes, and other tax regulations, and changes
thereto;
• changes in tax laws, treaties or regulations, or their
interpretation;
• taxation relating to our distributors;
• product liability claims;
• any collateral impact resulting from the ongoing worldwide
financial “crisis,” including the availability of liquidity to us, our
customers and our suppliers or the willingness of our customers to
purchase products in a recessionary economic environment; and
• whether we will purchase any of our shares in the open markets
or otherwise.
We do not undertake any obligation to update or release any revisions
to any forward-looking statement or to report any events or circumstances
after the date hereof or to reflect the occurrence of unanticipated
events, except as required by law.
|
|
|
|
|
|
|
|
|
|
|
RESULTS OF OPERATIONS:
|
|
|
|
|
|
|
|
|
|
|
|
Herbalife Ltd.
|
|
|
Consolidated Statements of Income
|
|
|
(In thousands, except per share data)
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended
|
|
Nine Months Ended
|
|
|
|
9/30/2009
|
|
9/30/2008
|
|
9/30/2009
|
|
9/30/2008
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$
|
140,829
|
|
$
|
135,840
|
|
$
|
402,294
|
|
$
|
387,665
|
|
Mexico
|
|
|
68,290
|
|
|
91,632
|
|
|
193,881
|
|
|
287,962
|
|
South and Central America
|
|
|
93,035
|
|
|
94,364
|
|
|
253,702
|
|
|
299,066
|
|
EMEA
|
|
|
123,334
|
|
|
135,434
|
|
|
373,222
|
|
|
453,303
|
|
Asia Pacific
|
|
|
129,240
|
|
|
103,736
|
|
|
357,723
|
|
|
313,830
|
|
China
|
|
|
45,490
|
|
|
41,193
|
|
|
112,884
|
|
|
104,510
|
|
Worldwide net sales
|
|
|
600,218
|
|
|
602,199
|
|
|
1,693,706
|
|
|
1,846,336
|
|
Cost of Sales
|
|
|
131,777
|
|
|
116,620
|
|
|
356,619
|
|
|
362,335
|
|
Gross Profit
|
|
|
468,441
|
|
|
485,579
|
|
|
1,337,087
|
|
|
1,484,001
|
|
Royalty Overrides
|
|
|
194,639
|
|
|
200,323
|
|
|
556,921
|
|
|
628,343
|
|
SGA
|
|
|
195,968
|
|
|
196,761
|
|
|
568,220
|
|
|
584,274
|
|
Operating Income
|
|
|
77,834
|
|
|
88,495
|
|
|
211,946
|
|
|
271,384
|
|
Interest Expense - net
|
|
|
1,037
|
|
|
3,407
|
|
|
4,087
|
|
|
10,364
|
|
Income before income taxes
|
|
|
76,797
|
|
|
85,088
|
|
|
207,859
|
|
|
261,020
|
|
Income Taxes
|
|
|
18,902
|
|
|
27,004
|
|
|
60,169
|
|
|
73,489
|
|
Net Income
|
|
|
57,895
|
|
|
58,084
|
|
|
147,690
|
|
|
187,531
|
|
|
|
|
|
|
|
|
|
|
|
Basic Shares
|
|
|
61,234
|
|
|
63,594
|
|
|
61,467
|
|
|
64,062
|
|
Diluted Shares
|
|
|
63,397
|
|
|
65,439
|
|
|
63,049
|
|
|
66,269
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS
|
|
$
|
0.95
|
|
$
|
0.91
|
|
$
|
2.40
|
|
$
|
2.93
|
|
Diluted EPS
|
|
$
|
0.91
|
|
$
|
0.89
|
|
$
|
2.34
|
|
$
|
2.83
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per share
|
|
$
|
0.20
|
|
$
|
0.20
|
|
$
|
0.60
|
|
$
|
0.60
|
|
|
|
Herbalife Ltd.
|
|
Consolidated Balance Sheets
|
|
(In thousands)
|
|
(Unaudited)
|
|
|
|
Sept 30,
|
|
Dec 31,
|
|
|
|
2009
|
|
2008
|
|
ASSETS
|
|
|
|
|
|
Current Assets:
|
|
|
|
|
|
Cash & cash equivalents
|
|
$
|
215,401
|
|
|
$
|
150,847
|
|
|
Receivables, net
|
|
|
84,747
|
|
|
|
70,002
|
|
|
Inventory, net
|
|
|
133,376
|
|
|
|
134,392
|
|
|
Prepaid expenses and other current assets
|
|
|
97,510
|
|
|
|
89,214
|
|
|
Deferred income taxes
|
|
|
43,490
|
|
|
|
40,313
|
|
|
Total Current Assets
|
|
|
574,524
|
|
|
|
484,768
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
176,774
|
|
|
|
175,492
|
|
|
Deferred compensation plan assets
|
|
|
17,076
|
|
|
|
15,754
|
|
|
Deferred financing cost, net
|
|
|
1,622
|
|
|
|
1,989
|
|
|
Marketing related intangibles
|
|
|
310,060
|
|
|
|
310,060
|
|
|
Goodwill
|
|
|
115,351
|
|
|
|
110,677
|
|
|
Other assets
|
|
|
23,079
|
|
|
|
22,578
|
|
|
|
|
|
|
|
|
Total Assets
|
|
$
|
1,218,486
|
|
|
$
|
1,121,318
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
|
|
|
|
Current Liabilities:
|
|
|
|
|
|
Accounts payable
|
|
$
|
41,324
|
|
|
$
|
41,084
|
|
|
Royalty Overrides
|
|
|
144,170
|
|
|
|
130,369
|
|
|
Accrued compensation
|
|
|
57,105
|
|
|
|
60,629
|
|
|
Accrued expenses
|
|
|
127,271
|
|
|
|
104,795
|
|
|
Current portion of long term debt
|
|
|
12,361
|
|
|
|
15,117
|
|
|
Advance sales deposits
|
|
|
35,034
|
|
|
|
12,603
|
|
|
Income taxes payable
|
|
|
24,093
|
|
|
|
37,302
|
|
|
Total Current Liabilities
|
|
|
441,358
|
|
|
|
401,899
|
|
|
|
|
|
|
|
|
Non-current liabilities
|
|
|
|
|
|
Long-term debt, net of current portion
|
|
|
297,482
|
|
|
|
336,514
|
|
|
Deferred compensation
|
|
|
15,970
|
|
|
|
13,979
|
|
|
Deferred income taxes
|
|
|
102,648
|
|
|
|
103,675
|
|
|
Other non-current liabilities
|
|
|
23,695
|
|
|
|
23,520
|
|
|
Total Liabilities
|
|
|
881,153
|
|
|
|
879,587
|
|
|
|
|
|
|
|
|
Contingencies
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' equity:
|
|
|
|
|
|
Common shares
|
|
|
122
|
|
|
|
123
|
|
|
Additional paid in capital
|
|
|
210,748
|
|
|
|
197,715
|
|
|
Accumulated other comprehensive loss
|
|
|
(26,956
|
)
|
|
|
(28,614
|
)
|
|
Retained earnings
|
|
|
153,419
|
|
|
|
72,507
|
|
|
Total Shareholders' Equity
|
|
|
337,333
|
|
|
|
241,731
|
|
|
|
|
|
|
|
|
Total Liabilities and Shareholders' Equity
|
|
$
|
1,218,486
|
|
|
$
|
1,121,318
|
|
|
|
|
Herbalife Ltd.
|
|
Consolidated Statements of Cash Flows
|
|
(In thousands)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
|
|
|
9/30/2009
|
|
9/30/2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
Net income
|
|
$
|
147,690
|
|
|
$
|
187,531
|
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
Depreciation and amortization
|
|
|
45,646
|
|
|
|
34,789
|
|
|
Deficiency (Excess) tax benefits from share-based payment
arrangements
|
|
|
759
|
|
|
|
(12,659
|
)
|
|
Share based compensation expenses
|
|
|
15,100
|
|
|
|
13,877
|
|
|
Amortization of discount and deferred financing costs
|
|
|
367
|
|
|
|
359
|
|
|
Deferred income taxes
|
|
|
(3,098
|
)
|
|
|
1,348
|
|
|
Unrealized foreign exchange transaction loss (gain)
|
|
|
6,763
|
|
|
|
(4,580
|
)
|
|
Other
|
|
|
233
|
|
|
|
891
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
Receivables
|
|
|
(9,265
|
)
|
|
|
(16,483
|
)
|
|
Inventories
|
|
|
10,451
|
|
|
|
(11,232
|
)
|
|
Prepaid expenses and other current assets
|
|
|
(5,724
|
)
|
|
|
(37,392
|
)
|
|
Other assets
|
|
|
354
|
|
|
|
(1,613
|
)
|
|
Accounts payable
|
|
|
(4,851
|
)
|
|
|
8,155
|
|
|
Royalty overrides
|
|
|
9,525
|
|
|
|
14,201
|
|
|
Accrued expenses and accrued compensation
|
|
|
5,870
|
|
|
|
18,851
|
|
|
Advance sales deposits
|
|
|
21,011
|
|
|
|
6,877
|
|
|
Income taxes payable
|
|
|
(15,529
|
)
|
|
|
359
|
|
|
Deferred compensation plan liability
|
|
|
1,992
|
|
|
|
(1,682
|
)
|
|
NET CASH PROVIDED BY OPERATING ACTIVITIES
|
|
|
227,294
|
|
|
|
201,597
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
Purchases of property
|
|
|
(41,776
|
)
|
|
|
(68,325
|
)
|
|
Proceeds from sale of property
|
|
|
93
|
|
|
|
67
|
|
|
Acquisition of business
|
|
|
(10,000
|
)
|
|
|
0
|
|
|
Deferred compensation plan assets
|
|
|
(1,321
|
)
|
|
|
1,488
|
|
|
NET CASH USED IN INVESTING ACTIVITIES
|
|
|
(53,004
|
)
|
|
|
(66,770
|
)
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
Dividends paid
|
|
|
(36,727
|
)
|
|
|
(38,338
|
)
|
|
Borrowings from long-term debt
|
|
|
138,974
|
|
|
|
50,000
|
|
|
Principal payments on long-term debt
|
|
|
(180,540
|
)
|
|
|
(117,652
|
)
|
|
Increase in deferred financing costs
|
|
|
0
|
|
|
|
(75
|
)
|
|
Share repurchases
|
|
|
(33,630
|
)
|
|
|
(94,193
|
)
|
|
(Deficiency) Excess tax benefits from share-based payment
arrangements
|
|
|
(759
|
)
|
|
|
12,659
|
|
|
Proceeds from exercise of stock options and sale of stock under
employee stock purchase plan
|
|
|
2,209
|
|
|
|
18,275
|
|
|
NET CASH USED IN FINANCING ACTIVITIES
|
|
|
(110,473
|
)
|
|
|
(169,324
|
)
|
|
EFFECT OF EXCHANGE RATE CHANGES ON CASH
|
|
|
737
|
|
|
|
(3,516
|
)
|
|
NET CHANGE IN CASH AND CASH EQUIVALENTS
|
|
|
64,554
|
|
|
|
(38,013
|
)
|
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
|
|
|
150,847
|
|
|
|
187,407
|
|
|
CASH AND CASH EQUIVALENTS, END OF PERIOD
|
|
$
|
215,401
|
|
|
$
|
149,394
|
|
|
CASH PAID DURING THE PERIOD
|
|
|
|
|
|
Interest paid
|
|
$
|
8,443
|
|
|
$
|
10,365
|
|
|
Income taxes paid
|
|
$
|
77,397
|
|
|
$
|
68,597
|
|
|
NON CASH ACTIVITIES
|
|
|
|
|
|
Assets acquired under capital leases and other long-term debt
|
|
$
|
339
|
|
|
$
|
28,785
|
|
|
|
|
Herbalife Ltd
|
|
New Sales Leaders by Region
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For Three Months Ended September 30, 2009
|
|
For the Nine Months Ended September 30, 2009
|
|
|
|
2009
|
|
2008
|
|
% Change
|
|
|
2009
|
|
2008
|
|
% Change
|
|
|
North America
|
|
10,569
|
|
11,723
|
|
(9.8
|
%)
|
|
29,095
|
|
33,862
|
|
(14.1
|
%)
|
|
Mexico
|
|
6,132
|
|
6,243
|
|
(1.8
|
%)
|
|
16,799
|
|
21,810
|
|
(23.0
|
%)
|
|
South & Central America
|
|
6,376
|
|
10,758
|
|
(40.7
|
%)
|
|
22,212
|
|
36,666
|
|
(39.4
|
%)
|
|
EMEA
|
|
5,222
|
|
6,052
|
|
(13.7
|
%)
|
|
17,162
|
|
21,107
|
|
(18.7
|
%)
|
|
Asia Pacific (excluding China)
|
|
13,262
|
|
10,532
|
|
25.9
|
%
|
|
37,182
|
|
30,676
|
|
21.2
|
%
|
|
Total New Supervisors
|
|
41,561
|
|
45,308
|
|
(8.3
|
%)
|
|
122,450
|
|
144,121
|
|
(15.0
|
%)
|
|
New China Sales Employees
|
|
6,479
|
|
7,283
|
|
(11.0
|
%)
|
|
17,577
|
|
19,500
|
|
(9.9
|
%)
|
|
Worldwide Total New Sales Leaders (1)
|
|
48,040
|
|
52,591
|
|
(8.7
|
%)
|
|
140,027
|
|
163,621
|
|
(14.4
|
%)
|
|
|
|
Herbalife Ltd
|
|
Total Sales Leaders by Region
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30
|
|
|
|
2009
|
|
2008
|
|
% Change
|
|
|
North America
|
|
87,348
|
|
91,496
|
|
(4.5
|
%)
|
|
Mexico
|
|
64,438
|
|
76,700
|
|
(16.0
|
%)
|
|
South & Central America
|
|
84,936
|
|
96,285
|
|
(11.8
|
%)
|
|
EMEA
|
|
66,454
|
|
75,071
|
|
(11.5
|
%)
|
|
Asia Pacific (excluding China)
|
|
89,750
|
|
80,706
|
|
11.2
|
%
|
|
Total Supervisors
|
|
392,926
|
|
420,258
|
|
(6.5
|
%)
|
|
China Sales Employees
|
|
44,199
|
|
41,580
|
|
6.3
|
%
|
|
Worldwide Total Sales Leaders (1)
|
|
437,125
|
|
461,838
|
|
(5.4
|
%)
|
Note: (1) – We refer to supervisors who qualified in 69 countries under
our traditional marketing plan plus China sales employees collectively
as ‘Sales Leaders’.
|
|
|
Herbalife Ltd
|
|
Volume Points by Region
|
|
(Unaudited, In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
|
|
|
2009
|
|
2008
|
|
% Change
|
|
|
2009
|
|
2008
|
|
% Change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
207,612
|
|
202,772
|
|
2.4
|
%
|
|
594,567
|
|
586,190
|
|
1.4
|
%
|
|
Mexico
|
|
126,375
|
|
132,083
|
|
(4.3
|
%)
|
|
371,035
|
|
433,023
|
|
(14.3
|
%)
|
|
South & Central America
|
|
102,166
|
|
101,475
|
|
0.7
|
%
|
|
302,708
|
|
331,476
|
|
(8.7
|
%)
|
|
EMEA
|
|
109,429
|
|
116,218
|
|
(5.8
|
%)
|
|
350,871
|
|
382,282
|
|
(8.2
|
%)
|
|
Asia Pacific (excluding China)
|
|
148,184
|
|
108,840
|
|
36.1
|
%
|
|
418,591
|
|
325,567
|
|
28.6
|
%
|
|
China
|
|
32,270
|
|
30,224
|
|
6.8
|
%
|
|
85,904
|
|
84,317
|
|
1.9
|
%
|
|
Worldwide
|
|
726,036
|
|
691,612
|
|
5.0
|
%
|
|
2,123,676
|
|
2,142,855
|
|
(0.9
|
%)
|
|
|
|
SUPPLEMENTAL INFORMATION
|
|
SCHEDULE A: FINANCIAL GUIDANCE
|
|
|
|
2009 Guidance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months and Twelve Months Ending December 31, 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ending
|
|
Twelve Months Ending
|
|
|
|
December 31, 2009
|
|
December 31, 2009
|
|
|
|
Low
|
|
High
|
|
Low
|
|
High
|
|
|
|
|
|
|
|
|
|
|
|
Volume point growth vs 2008
|
|
|
8.5
|
%
|
|
|
9.5
|
%
|
|
|
1.0
|
%
|
|
|
1.5
|
%
|
|
Net sales growth vs 2008
|
|
|
15.5
|
%
|
|
|
16.5
|
%
|
|
|
(3.0
|
%)
|
|
|
(2.5
|
%)
|
|
EPS (1) (2) (3) (4)
|
|
$
|
0.88
|
|
|
$
|
0.91
|
|
|
$
|
3.19
|
|
|
$
|
3.22
|
|
|
Cap Ex ($ millions)
|
|
$
|
18.0
|
|
|
$
|
23.0
|
|
|
$
|
60.0
|
|
|
$
|
65.0
|
|
|
Effective Tax Rate (4)
|
|
|
30.0
|
%
|
|
|
31.0
|
%
|
|
|
30.5
|
%
|
|
|
31.0
|
%
|
(1) Excludes the potential impact of expenses
relating to the company’s December 2008 restructuring. (2)
Excludes any accretion/dilution impact should the company elect to
repurchase shares under its share repurchase program. (3)
Excludes the impact of repatriating dollars from Venezuela at an
exchange rate that is less favorable than the official exchange rate. (4)
Excludes the impact of the expense resulting from an international
income tax audit settlement, expiration of statute of limitation of a
reserved issue, and the expected Q4 reversal of a prior adjustment to
income tax accrual.
|
|
|
|
|
|
|
2010 Guidance
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ending December 31, 2010
|
|
|
|
|
|
|
|
|
|
Twelve Months Ending
|
|
|
|
December 31, 2010
|
|
|
|
Low
|
|
High
|
|
|
|
|
|
|
|
Volume point growth vs 2009
|
|
|
5.0
|
%
|
|
|
6.0
|
%
|
|
Net sales growth vs 2009
|
|
|
11.0
|
%
|
|
|
13.0
|
%
|
|
EPS (1) (2)
|
|
$
|
3.50
|
|
|
$
|
3.65
|
|
|
Cap Ex ($ millions)
|
|
$
|
65.0
|
|
|
$
|
75.0
|
|
|
Effective Tax Rate
|
|
|
30.0
|
%
|
|
|
31.0
|
%
|
(1) Includes utilization of $50 million of the company’s share
repurchase program. (2) While 2010 guidance excludes the
impact of repatriating approximately 100 million Venezuelan Bolivars of
our existing excess cash in Venezuela, 2010 guidance does include the
ongoing repatriation of excess cash generated in Venezuela during 2010.
|
|
|
SCHEDULE B: NET SALES OF TOP 10 COUNTRIES
|
|
(In Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q3 2009
|
|
|
|
|
|
Q3 2008
|
|
|
|
|
|
|
|
Currency
|
|
FX Benefit
|
|
|
|
|
|
|
|
Currency
|
|
FX Benefit
|
|
|
|
|
|
Reported
|
|
Adjusted
|
|
(Loss)
|
|
|
|
|
|
Reported
|
|
Adjusted
|
|
(Loss)
|
|
1
|
|
USA
|
|
$
|
136.7
|
|
$
|
136.7
|
|
$
|
0.0
|
|
|
1
|
|
USA
|
|
$
|
130.9
|
|
$
|
130.9
|
|
$
|
0.0
|
|
|
2
|
|
Mexico
|
|
$
|
68.3
|
|
$
|
87.8
|
|
|
($19.5
|
)
|
|
2
|
|
Mexico
|
|
$
|
91.6
|
|
$
|
86.1
|
|
$
|
5.5
|
|
|
3
|
|
China
|
|
$
|
45.5
|
|
$
|
45.4
|
|
$
|
0.1
|
|
|
3
|
|
Brazil
|
|
$
|
43.6
|
|
$
|
37.8
|
|
$
|
5.8
|
|
|
4
|
|
Brazil
|
|
$
|
45.1
|
|
$
|
50.7
|
|
|
($5.6
|
)
|
|
4
|
|
China
|
|
$
|
41.2
|
|
$
|
37.3
|
|
$
|
3.9
|
|
|
5
|
|
Taiwan
|
|
$
|
41.3
|
|
$
|
43.3
|
|
|
($2.0
|
)
|
|
5
|
|
Taiwan
|
|
$
|
32.4
|
|
$
|
30.7
|
|
$
|
1.7
|
|
|
6
|
|
South Korea
|
|
$
|
33.4
|
|
$
|
38.9
|
|
|
($5.5
|
)
|
|
6
|
|
Italy
|
|
$
|
27.7
|
|
$
|
25.3
|
|
$
|
2.4
|
|
|
7
|
|
Italy
|
|
$
|
29.2
|
|
$
|
30.8
|
|
|
($1.6
|
)
|
|
7
|
|
Korea
|
|
$
|
20.8
|
|
$
|
23.9
|
|
|
($3.1
|
)
|
|
8
|
|
Venezuela
|
|
$
|
21.9
|
|
$
|
21.9
|
|
$
|
0.0
|
|
|
8
|
|
Venezuela
|
|
$
|
15.9
|
|
$
|
15.9
|
|
$
|
0.0
|
|
|
9
|
|
Malaysia
|
|
$
|
12.3
|
|
$
|
13.0
|
|
|
($0.7
|
)
|
|
9
|
|
France
|
|
$
|
13.2
|
|
$
|
12.1
|
|
$
|
1.1
|
|
|
10
|
|
Japan
|
|
$
|
11.8
|
|
$
|
12.5
|
|
|
($0.7
|
)
|
|
10
|
|
Japan
|
|
$
|
13.0
|
|
$
|
11.9
|
|
$
|
1.1
|
|
|
Total of Top 10
|
|
$
|
445.5
|
|
$
|
481.0
|
|
|
($35.5
|
)
|
|
Total of Top 10
|
|
$
|
430.3
|
|
$
|
411.9
|
|
$
|
18.4
|
|
|
TOTAL NET SALES
|
|
$
|
600.2
|
|
$
|
647.4
|
|
|
($47.2
|
)
|
|
TOTAL NET SALES
|
|
$
|
602.2
|
|
$
|
576.4
|
|
$
|
25.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note: Currency adjusted net sales use the prior year foreign
currency rates to adjust current year reported net sales figures.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SCHEDULE C: VOLUME POINTS FOR TOP 10 COUNTRIES
|
|
(In Millions)
|
|
|
|
|
|
Q3 2009
|
|
|
|
|
|
Q3 2008
|
|
1
|
|
USA
|
|
201.8
|
|
1
|
|
USA
|
|
196.3
|
|
2
|
|
Mexico
|
|
126.4
|
|
2
|
|
Mexico
|
|
132.1
|
|
3
|
|
Taiwan
|
|
51.3
|
|
3
|
|
Brazil
|
|
42.7
|
|
4
|
|
Brazil
|
|
45.9
|
|
4
|
|
Taiwan
|
|
37.4
|
|
5
|
|
Korea
|
|
41.6
|
|
5
|
|
China
|
|
30.2
|
|
6
|
|
China
|
|
32.3
|
|
6
|
|
Korea
|
|
22.7
|
|
7
|
|
Italy
|
|
22.9
|
|
7
|
|
Italy
|
|
21.5
|
|
8
|
|
Venezuela
|
|
16.1
|
|
8
|
|
Venezuela
|
|
11.8
|
|
9
|
|
Malaysia
|
|
12.5
|
|
9
|
|
Malaysia
|
|
10.7
|
|
10
|
|
India
|
|
9.5
|
|
10
|
|
Peru
|
|
10.6
|
|
|
|
Total of Top 10
|
|
560.3
|
|
|
|
Total of Top 10
|
|
516.0
|
|
TOTAL VOLUME POINTS
|
|
726.0
|
|
TOTAL VOLUME POINTS
|
|
691.6
|
SCHEDULE D: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES (Unaudited) (Dollars
in Thousands, Except Per Share Data)
In addition to its reported results, the Company has included in the
tables below adjusted results that the Securities and Exchange
Commission defines as “non-GAAP financial measures.” Management
believes that such non-GAAP financial measures, when read in conjunction
with the Company’s reported results, can provide useful supplemental
information for investors analyzing period to period comparisons of the
Company’s results.
The following is a reconciliation of net income, presented and reported
in accordance with U.S. generally accepted accounting principles, to net
income adjusted for certain items:
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
|
|
9/30/2009
|
|
|
|
9/30/2008
|
|
|
9/30/2009
|
|
|
|
9/30/2008
|
|
Net income, as reported
|
|
$
|
57,895
|
|
|
$
|
58,084
|
|
$
|
147,690
|
|
|
$
|
187,531
|
|
Restructuring Expenses associated with realignment for growth
initiative (1)
|
|
|
494
|
|
|
|
-
|
|
|
899
|
|
|
|
1,071
|
|
Expiration of statutes of limitations
|
|
|
(4,852
|
)
|
|
|
-
|
|
|
(4,852
|
)
|
|
|
-
|
|
Tax expense resulting from an international income tax audit
settlement
|
|
|
537
|
|
|
|
-
|
|
|
1,628
|
|
|
|
-
|
|
Net income, as adjusted
|
|
$
|
54,074
|
|
|
$
|
58,084
|
|
$
|
145,365
|
|
|
$
|
188,602
|
The following is a reconciliation of diluted earnings per share,
presented and reported in accordance with U.S. generally accepted
accounting principles, to diluted earnings per share adjusted for
certain items:
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
|
9/30/2009
|
|
9/30/2008
|
|
9/30/2009
|
|
9/30/2008
|
|
Diluted earnings per share, as reported
|
|
$
|
0.91
|
|
|
$
|
0.89
|
|
$
|
2.34
|
|
|
$
|
2.83
|
|
Restructuring Expenses associated with realignment for growth
initiative (1)
|
|
|
0.01
|
|
|
|
|
|
0.01
|
|
|
|
0.02
|
|
Expiration of statutes of limitations
|
|
|
(0.08
|
)
|
|
|
-
|
|
|
(0.08
|
)
|
|
|
-
|
|
Tax expense resulting from an international income tax audit
settlement
|
|
|
0.01
|
|
|
|
-
|
|
|
0.03
|
|
|
|
-
|
|
Diluted earnings per share, as adjusted (2)
|
|
$
|
0.85
|
|
|
$
|
0.89
|
|
$
|
2.31
|
|
|
$
|
2.85
|
The following is a reconciliation of total long-term debt to net debt:
|
|
|
9/30/2009
|
|
12/31/2008
|
|
|
|
|
|
|
|
Total long-term debt (current and long-term portion)
|
|
$
|
309,843
|
|
$
|
351,631
|
|
Less: Cash and cash equivalents
|
|
|
215,401
|
|
|
150,847
|
|
Net debt
|
|
$
|
94,442
|
|
$
|
200,784
|
|
(1)
|
|
The restructuring charge adjustments reflect items that although
they, or similar items, might recur are of a nature and magnitude
that identifying them separately provides investors with a greater
ability to project the Company’s future performance.
|
|
(2)
|
|
Amounts may not total due to rounding
|
Source: Herbalife Ltd.
Herbalife Ltd. Media Contact: Barbara
Henderson SVP, Worldwide Corp. Comm. 213-745-0517 Investor
Contact: Amy Greene VP, Investor Relations 213-745-0504
|
|